Koers Medical Marijuana, Inc. Other OTC
Aandelen
MJNA
US58463A1051
Farmaceutische producten
Omzet 2013 | 5,06 mln. 4,73 mln. | Omzet 2014 | 14,52 mln. 13,58 mln. | Marktkapitalisatie | 108 mln. 101 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2013 | 24 mln. 22,45 mln. | Nettowinst (verlies) 2014 | -4 mln. -3,74 mln. | EV/omzet 2013 | 23,2 x |
Nettoliquiditeiten 2013 | 29,54 mln. 27,62 mln. | Nettoschuld 2014 | 25,84 mln. 24,16 mln. | EV/omzet 2014 | 9,22 x |
K/w-verhouding 2013 |
5,97
x | K/w-verhouding 2014 |
-45,2
x | Werknemers | - |
Dividendrendement 2013 * |
-
| Dividendrendement 2014 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Timothy Scott
CEO | Chief Executive Officer | 71 | 18-03-15 |
Mike Kolinski
CTO | Chief Tech/Sci/R&D Officer | - | 29-11-22 |
Chris Prine
BRD | Director/Board Member | - | 18-03-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Timothy Scott
CEO | Chief Executive Officer | 71 | 18-03-15 |
Director/Board Member | 76 | 18-03-15 | |
Chris Prine
BRD | Director/Board Member | - | 18-03-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+23,05% | 3,66 mld. | |
+109,78% | 2 mld. | |
+87,30% | 61,69 mln. |